Le Lézard
Classified in: Health
Subject: PLW

Qualigen Announces New Patent Issued for its FastPack® 2.0 System in China


CARLSBAD, Calif., Nov. 28, 2018 /PRNewswire/ -- Qualigen, Inc., a privately-owned company that provides novel diagnostic and therapeutic technologies for the treatment of cancer and infectious diseases, announced today the issuance of China Patent Number ZL 2017 30589986.5, which covers the design of Qualigen's novel FastPack 2.0 Sample Port.  The patent, which provides protection until November 2027, is part of a family of patents and patent applications that protect Qualigen's FastPack "Laboratory in a Pouch" rapid immunoassay diagnostic technology.  "We are pleased to strengthen our intellectual property protection with the addition of this new patent in China for our next-generation FastPack 2.0 System," stated Michael S. Poirier, Chief Executive Officer of Qualigen. "It is a key part of our continuing strategy to protect, improve and expand the utility of our FastPack and FastPack 2.0 diagnostic technologies in the U.S. and worldwide.  To date, we have over 40 issued patents in this space."

About Qualigen, Inc.
Qualigen, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including its flagship FastPack® point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases.  For more information, visit www.qualigeninc.com.

 

 

SOURCE Qualigen, Inc.


These press releases may also interest you

at 08:16
Canadian health care providers now have access to clinical tools and resources they need to better support older adults experiencing...

at 08:15
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it will be attending the LSX World Congress (29-30 April) and presenting at Bio?quity Europe (12-14 May). The...

at 08:15
Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a potential new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations highlighting positive efficacy and safety...

at 08:15
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Colleen Sjogren as Chief Commercial Officer. Ms....

at 08:15
Axiom Health, a leading provider of data analytics solutions for the medical device industry, today announced the appointments of Russell "Rusty" Lewis as Chief Executive Officer (CEO) and Jim Best as Chief Commercial Officer (CCO). These...

at 08:15
GlobeStar Therapeutics Corporation (GSTC), is a clinical stage pharmaceutical company focused on advancing new therapies for Multiple Sclerosis (MS) and other neurological diseases, including but not limited to Rheumatoid Arthritis (RA), released on...



News published on and distributed by: